Clinical Trial Update: Oral Azacitidine for the Treatment of Relapsed or Refractory T-cell Large Granular Lymphocytic Leukemia [Phase 1, Phase 2]

View source ↗

Summary

This entry notes an ongoing Phase 1/2 clinical trial evaluating oral azacitidine for relapsed or refractory T-cell large granular lymphocytic leukemia. The stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Large Granular Lymphocytic Leukemia

Drugs mentioned

• Onureg (azacitidine)

Snippet

Sponsor: Jonathan Brammer | Conditions: T-Cell Large Granular Lymphocyte Leukemia | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING